The bill updates CDC advisory-committee law in a way that could improve public-health decisionmaking but creates short-term legal ambiguity and risks narrowing stakeholder input and oversight.
Federal employees, state governments, and hospitals/health-systems will have updated statutory guidance for CDC advisory committees that could clarify roles and improve public-health decisionmaking and coordination.
Federal employees, state governments, and hospitals/health-systems may face temporary legal ambiguity about advisory committee membership, duties, or deadlines while the prior subsection is replaced, which could delay CDC actions or create operational confusion.
State governments and hospitals/health-systems could lose input into CDC policy if the new subsection narrows or limits advisory committee membership or duties, reducing stakeholder influence on public-health guidance.
Taxpayers and federal employees could face weaker accountability and reduced transparency over CDC actions if the replacement language limits oversight or disclosure requirements.
Based on analysis of 2 sections of legislative text.
Replaces subsection (h) of 42 U.S.C. § 280m—altering advisory-committee provisions and CDC responsibilities—exact new language not provided.
Introduced July 17, 2025 by Amy Klobuchar · Last progress July 17, 2025
Replaces subsection (h) of 42 U.S.C. § 280m to insert new, unspecified language and establishes a short title for the measure. The change directly alters the statutory text that governs advisory-committee provisions and the Secretary of Health and Human Services’ (CDC) roles to the extent that the new subsection differs from the old one. Because the actual replacement text is not provided, the practical effects are uncertain: the amendment could change membership, duties, deadlines, reporting requirements, or other administrative terms tied to CDC advisory committees or related responsibilities. No new funding, effective date, or detailed implementation steps are specified in the provided text.